- Research Tracker
- Supplement safety
- Omega-3 fatty acids and fish oil
What public sources say about the safety of omega-3 fatty acids and fish oil: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.
Interactions and safety, in NIH's words
Omega-3 dietary supplements, such as fish oil, have the potential to interact with medications. One example is provided below. People taking these and other medications on a regular basis should discuss possible interactions with their health care providers.
Fish oil can have antiplatelet effects at high doses, although it appears to be less potent than aspirin [197,198]. Fish oil might prolong clotting times, as indicated by an elevated international normalized ratio (INR), when it is taken with warfarin [199], but most research indicates that doses of 3–6 g/day fish oil do not significantly affect the anticoagulant status of patients taking warfarin [200]. The authors of a 2014 review concluded that omega-3s do not affect the risk of clinically significant bleeding [201], and the FDA-approved package inserts for omega-3 pharmaceuticals state that studies with omega-3s have not produced "clinically significant bleeding episodes" [202]. However, these package inserts also state that patients taking these products with anticoagulants should be monitored periodically for changes in INR.
Medicines covered in that section: Warfarin (Coumadin) and similar anticoagulants.
Quoted from the “Interactions with Medications” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.
FDA adverse-event reports (CAERS)
Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “FISH OIL”, “OMEGA-3”, “OMEGA 3”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.
Combination products: 165 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 756 reports where a product is named for omega-3 fatty acids and fish oil alone. This split is made from product names and can misfile some products. Most-reported products: Fish Oil (34); Naturemade Fish Oil (17); Krill Omega-3 Super Formula (15); Nature Made Fish Oil (14); Naturemade Fish Oil 1200 Mg (13); Naturemade Full Strength Mini Omega 3 (12).
| Most reported reactions (single-ingredient products) | Reports |
|---|---|
| Dyspnoea | 111 |
| Choking | 97 |
| Diarrhoea | 81 |
| Nausea | 65 |
| Vomiting | 64 |
| Foreign body | 54 |
| Hypersensitivity | 50 |
| Dizziness | 50 |
| Blood pressure increased | 36 |
| Headache | 34 |
| Abdominal pain upper | 34 |
| Pain | 33 |
Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (530), Hospitalization (174), Visited a Health Care Provider (158), Visited Emergency Room (119), Other Serious Outcome (100), Life Threatening (87), Required Intervention (35), Other Outcome (31).
Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.
Registered trials
188 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.
- Treatment of Anxiety and Anorexia Nervosa in Adolescents Completed Results posted
- Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids Completed Results posted
- Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation Completed Results posted
- Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation Completed Results posted
- The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children Completed Results posted
- Omega-3 Supplementation to ADHD Medication in Children Completed Results posted
- The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder Completed Results posted
- Effect of Omega-3 Fatty Acid on Cortical Function in ADHD Completed Results posted
- Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation Completed Results posted
- Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors Completed Results posted
- Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer Completed Results posted
- Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures Completed Results posted
- Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure Completed Results posted
- Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients Completed Results posted
- Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients Completed Results posted
- Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach Completed Results posted
- The Role Of Omega-3 Fatty Acids In Adolescent Depression Completed Results posted
- Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder Completed Results posted
- Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression Completed Results posted
- Omega-3 Supplementation for Pediatric Migraine Completed Results posted